Last week, surgeons from the Mount Sinai School of Medicine in New York held a broadcast of a live complicated cath lab procedure involving Abiomed‘s Impella 2.5 left ventricular assist pump. The patient had a severely decreased left ventricular function and required hemodynamic assistance while rotational atherectomy was conducted and a stent placed.
More info about the case from an Abiomed press release:
The patient was a 58-year-old male with severe calcific multivessel and left main disease with severe LV dysfunction (LVEF of 25%). A normal LVEF typically ranges from 60 – 66 percent. Impella 2.5 was inserted to maintain left ventricular support and provide hemodynamic stability.
Video: Rotational Atherectomy followed by simultaneous kissing stent (SKS) technique for distal left main bifurcation using Impella assist device…
Press release: Impella 2.5 Patient Procedure at Mount Sinai Medical Center Featuring New Product Enhancements…
Product page: Impella 2.5…
Flashbacks: Abiomed Reports New Positive Impella 2.5 Results; Impella 2.5 Heart Pump Performs Well in a Feasibility Trial; Impella 2.5 Heart Pump Given Green Light in US; Impella Percutaneous VAD to be Studied for Acute MI Patients
(hat tip: MassDevice)